next acquisitionLast acquisition with options @$2. 4, at that time stock price was somewhere between $2. 8-$3.Every next acquisition was done by issuing options at a higher price than previous acquisition.Now, DOC has a problem. With this price they would have to go around $1.8, and that's significant drop.
So CEO cares about stock price very much, or at least he should.
I think they should do next acquisition all in cash.
I think cloudmd has a problem with short term. They need higher stock price, at least around $2.8 for next acquisition, and they have nothing big coming to excite the investors. The vaccine is out, and telehealth will slow down.If he can pull out some big organic deal it would the awesome. Something like to have an insurance company pioneering in their enterprise sector.
Wishful thinking.